IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor

American Journal of Pathology

Volumn 182, Issue 6, 2013, Pages 2345-2354

  Gerber, Scott A ^a   Sedlacek, Abigail L ^a   Cron, Kyle R ^a   Murphy, Shawn P ^a   Frelinger, John G ^a   Lord, Edith M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CD8+ T LYMPHOCYTE; COLON ADENOCARCINOMA; CONTROLLED STUDY; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE;

ADENOCARCINOMA; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; COLONIC NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION;

EID: 84878237101     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.02.041     Document Type: Article

References (38)

1. A.A. Lugade, J.P. Moran, S.A. Gerber, R.C. Rose, J.G. Frelinger, and E.M. Lord Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor J Immunol 174 2005 7516 7523
2. L. Apetoh, F. Ghiringhelli, A. Tesniere, M. Obeid, C. Ortiz, A. Criollo, G. Mignot, M.C. Maiuri, E. Ullrich, P. Saulnier, H. Yang, S. Amigorena, B. Ryffel, F.J. Barrat, P. Saftig, F. Levi, R. Lidereau, C. Nogues, J.P. Mira, A. Chompret, V. Joulin, F. Clavel-Chapelon, J. Bourhis, F. Andre, S. Delaloge, T. Tursz, G. Kroemer, and L. Zitvogel Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy Nat Med 13 2007 1050 1059
3. Y. Lee, S.L. Auh, Y. Wang, B. Burnette, Y. Meng, M. Beckett, R. Sharma, R. Chin, T. Tu, R.R. Weichselbaum, and Y.X. Fu Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment Blood 114 2009 589 595
4. T. Takeshima, K. Chamoto, D. Wakita, T. Ohkuri, Y. Togashi, H. Shirato, H. Kitamura, and T. Nishimura Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy Cancer Res 70 2010 2697 2706
5. Y. Meng, M.A. Beckett, H. Liang, H.J. Mauceri, N. van Rooijen, K.S. Cohen, and R.R. Weichselbaum Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy Cancer Res 70 2010 1534 1543
6. K. Kim, and W.H. McBride Modifying radiation damage Curr Drug Targets 11 2010 1352 1365
7. S. Demaria, N. Bhardwaj, W.H. McBride, and S.C. Formenti Combining radiotherapy and immunotherapy: a revived partnership Int J Radiat Oncol Biol Phys 63 2005 655 666
8. W.H. McBride, C.S. Chiang, J.L. Olson, C.C. Wang, J.H. Hong, F. Pajonk, G.J. Dougherty, K.S. Iwamoto, M. Pervan, and Y.P. Liao A sense of danger from radiation Radiat Res 162 2004 1 19
9. S.C. Formenti, and S. Demaria Systemic effects of local radiotherapy Lancet Oncol 10 2009 718 726
10. A.A. Lugade, E.W. Sorensen, S.A. Gerber, J.P. Moran, J.G. Frelinger, and E.M. Lord Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity J Immunol 180 2008 3132 3139
11. M.R. Zaidi, and G. Merlino The two faces of interferon-gamma in cancer Clin Cancer Res 17 2011 6118 6124
12. K. Taniguchi, M. Petersson, P. Hoglund, R. Kiessling, G. Klein, and K. Karre Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens Proc Natl Acad Sci U S A 84 1987 3405 3409
13. V.Y. Gorbacheva, D. Lindner, G.C. Sen, and D.J. Vestal The interferon (IFN)-induced GTPase, mGBP-2. Role in IFN-gamma-induced murine fibroblast proliferation J Biol Chem 277 2002 6080 6087
14. J.R. Brody, C.L. Costantino, A.C. Berger, T. Sato, M.P. Lisanti, C.J. Yeo, R.V. Emmons, and A.K. Witkiewicz Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival Cell Cycle 8 2009 1930 1934
15. J.B. Katz, A.J. Muller, and G.C. Prendergast Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape Immunol Rev 222 2008 206 221
16. G.C. Prendergast Immune escape as a fundamental trait of cancer: focus on IDO Oncogene 27 2008 3889 3900
17. S. Ostrand-Rosenberg, and P. Sinha Myeloid-derived suppressor cells: linking inflammation and cancer J Immunol 182 2009 4499 4506
18. T.H. Corbett, D.P. Griswold Jr., B.J. Roberts, J.C. Peckham, and F.M. Schabel Jr. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure Cancer Res 35 1975 2434 2439
19. D.B. Stetson, M. Mohrs, R.L. Reinhardt, J.L. Baron, Z.E. Wang, L. Gapin, M. Kronenberg, and R.M. Locksley Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function J Exp Med 198 2003 1069 1076
20. S.A. Gerber, and J.S. Pober IFN-alpha induces transcription of hypoxia-inducible factor-1alpha to inhibit proliferation of human endothelial cells J Immunol 181 2008 1052 1062
21. T.M. Blieden, A.J. McAdam, J.G. Frelinger, and E.M. Lord Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumor J Immunol 147 1991 1433 1438
22. S.A. Gerber, J.P. Moran, J.G. Frelinger, J.A. Frelinger, B.M. Fenton, and E.M. Lord Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts Br J Cancer 88 2003 1453 1461
23. S.A. Gerber, V.Y. Rybalko, C.E. Bigelow, A.A. Lugade, T.H. Foster, J.G. Frelinger, and E.M. Lord Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth Am J Pathol 169 2006 1739 1752
24. K.D. Mayer, K. Mohrs, S.R. Crowe, L.L. Johnson, P. Rhyne, D.L. Woodland, and M. Mohrs The functional heterogeneity of type 1 effector T cells in response to infection is related to the potential for IFN-gamma production J Immunol 174 2005 7732 7739
25. S. Gallucci, and P. Matzinger Danger signals: sOS to the immune system Curr Opin Immunol 13 2001 114 119
26. Y. Shi, J.E. Evans, and K.L. Rock Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 2003 516 521
27. D. Hanahan, and L.M. Coussens Accessories to the crime: functions of cells recruited to the tumor microenvironment Cancer Cell 21 2012 309 322
28. H. Li, X. Fan, and J. Houghton Tumor microenvironment: the role of the tumor stroma in cancer J Cell Biochem 101 2007 805 815
29. M.M. Mueller, and N.E. Fusenig Friends or foes - bipolar effects of the tumour stroma in cancer Nat Rev Cancer 4 2004 839 849
30. G. Valente, L. Ozmen, F. Novelli, M. Geuna, G. Palestro, G. Forni, and G. Garotta Distribution of interferon-gamma receptor in human tissues Eur J Immunol 22 1992 2403 2412
31. K.S. Kim, K.W. Kang, Y.B. Seu, S.H. Baek, and J.R. Kim Interferon-gamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells Mech Ageing Dev 130 2009 179 188
32. S. Goel, D.G. Duda, L. Xu, L.L. Munn, Y. Boucher, D. Fukumura, and R.K. Jain Normalization of the vasculature for treatment of cancer and other diseases Physiol Rev 91 2011 1071 1121
33. R.K. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 2005 58 62
34. Y. Lu, W. Yang, C. Qin, L. Zhang, J. Deng, S. Liu, and Z. Qin Responsiveness of stromal fibroblasts to IFN-gamma blocks tumor growth via angiostasis J Immunol 183 2009 6413 6421
35. B.D. Car, V.M. Eng, J.M. Lipman, and T.D. Anderson The toxicology of interleukin-12: a review Toxicol Pathol 27 1999 58 63
36. J.W. Mier, F.R. Aronson, R.P. Numerof, G. Vachino, and M.B. Atkins Toxicity of immunotherapy with interleukin-2 and lymphokine-activated killer cells Pathol Immunopathol Res 7 1988 459 476
37. N.K. Egilmez, Y.S. Jong, M.S. Sabel, J.S. Jacob, E. Mathiowitz, and R.B. Bankert In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity Cancer Res 60 2000 3832 3837
38. J. Puskas, D. Skrombolas, A. Sedlacek, E. Lord, M. Sullivan, and J. Frelinger Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases Immunology 133 2011 206 220